Caption Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Caption Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-61,380	Closed	-$5.1M	–	1896
2022 Q3	$3.8M	Buy	61,380 +33,880	+123%	+$2.37M	0.05%	430
2022 Q2	$2.19M	Buy	27,500 +2,500	+10%	+$237K	0.03%	637
2022 Q1	$2.63M	Sell	25,000 -9,300	-27%	-$906K	0.03%	658
2021 Q4	$3.7M	Sell	34,300 -52,700	-61%	-$5.75M	0.04%	564
2021 Q3	$9.53M	Buy	87,000 +63,000	+263%	+$6.54M	0.11%	242
2021 Q2	$2.25M	Sell	24,000 -107,086	-82%	-$9.85M	0.03%	645
2021 Q1	$12.1M	Buy	+131,086	New	+$11.1M	0.26%	87
2020 Q1	–	Sell	-37,800	Closed	-$1.37M	–	1244
2019 Q4	$1.37M	Buy	37,800 +33,800	+845%	+$1.04M	0.05%	435
2019 Q3	$109K	Buy	+4,000	New	+$103K	0.01%	633

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Caption Management's HZNP Position: Q4 2022 in Review

Caption Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 61,380 shares — an estimated $5.1M sold.

Caption Management first reported a position in HZNP in Q3 2019 and held it in 9 quarters. The position peaked at $12.1M in Q1 2021. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

Caption Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Caption Management sold 61,380 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $5.1M.
Caption Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2019 and held it in 9 quarters.
Caption Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $12.1M in Q1 2021.
615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.